BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26144698)

  • 1. Accumulation of (131)INa activity in renal cysts unrelated to metastatic disease in a patient with differentiated thyroid cancer.
    Castillo-Berrio C; Zelaya F; Loira F; Castrillón M; López A; Outomuro J
    Rev Esp Med Nucl Imagen Mol; 2016; 35(1):70-1. PubMed ID: 26144698
    [No Abstract]   [Full Text] [Related]  

  • 2. Differentiated thyroid carcinoma: Incremental diagnostic value of
    Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
    Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stunning with 131I diagnostic whole-body imaging of patients with thyroid cancer.
    Gerard SK; Dam HQ
    Radiology; 2005 Mar; 234(3):972-3; author reply 973-4. PubMed ID: 15734947
    [No Abstract]   [Full Text] [Related]  

  • 4. Esophageal diverticulum presenting as metastatic thyroid mass on iodine-131 scintigraphy.
    Rashid K; Johns W; Chasse K; Walker M; Gupta SM
    Clin Nucl Med; 2006 Jul; 31(7):405-8. PubMed ID: 16785810
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidental finding of hiatal hernia on (99m)Tc-sestamibi whole-body scan in thyroid cancer evaluation.
    Del Castillo-Matos R; Quirce R; Martínez-Rodríguez I; Medina-Quiroz P; Rubio-Vassallo A; Carril JM
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):163-4. PubMed ID: 22056002
    [No Abstract]   [Full Text] [Related]  

  • 6. 131I therapeutic efficacy is not influenced by stunning after diagnostic whole-body scanning.
    Dam HQ; Kim SM; Lin HC; Intenzo CM
    Radiology; 2004 Aug; 232(2):527-33. PubMed ID: 15286323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tracheostomy cannula as a cause of false positive result on the whole-body scan with (131)I in the follow-up of differentiated thyroid cancer].
    Vallejo Casas JA; Mena Bares ML; Gálvez Moreno MA; Latre Romero JM
    Rev Esp Med Nucl; 2011; 30(6):384-5. PubMed ID: 21546127
    [No Abstract]   [Full Text] [Related]  

  • 8. False positive uptake in post-treatment iodine-131 whole-body scans secondary to contamination.
    Schlosser J; Paliou M; Bravo-Vera R; Sheikh A; Gouller A
    Thyroid; 2007 Jan; 17(1):81-2. PubMed ID: 17274756
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diffuse sclerosing variant of papillary thyroid carcinoma].
    Manrique Franco K; Domínguez Fernández R; Lara Capellán JI; Renedo Pascual G; Rovira Loscos A
    Endocrinol Nutr; 2010 Dec; 57(10):500-2. PubMed ID: 20843752
    [No Abstract]   [Full Text] [Related]  

  • 10. Metastases in the sphenoidal sinus in a patient with papillary thyroid cancer.
    Argibay Vázquez S; Lancha Hernández C; Martínez Muñiz A
    Clin Transl Oncol; 2005 Aug; 7(7):324-7. PubMed ID: 16185596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioiodine therapy for papillary and follicular thyroid carcinoma.
    Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer.
    Sawka AM; Brierley JD; Tsang RW; Thabane L; Rotstein L; Gafni A; Straus S; Goldstein DP
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):457-80, x. PubMed ID: 18502337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic parotid tumor: a rare presentation for papillary carcinoma of thyroid.
    Malhotra G; Nair N; Awasare S; Baghel NS
    Clin Nucl Med; 2007 Jun; 32(6):488-90. PubMed ID: 17515766
    [No Abstract]   [Full Text] [Related]  

  • 14. Guidelines for the use of radio-iodine, thyroid hormone, and treatment of metastatic disease in patients with differentiated thyroid cancer.
    Paloyan E; Walker RP; Lawrence AM
    Surg Oncol Clin N Am; 1998 Oct; 7(4):665-80. PubMed ID: 9735128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope.
    Podnos YD; Smith DD; Wagman LD; Ellenhorn JD
    J Surg Oncol; 2007 Jul; 96(1):3-7. PubMed ID: 17567872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An interesting contamination artifact appearing in I-(131) whole-body imaging after ablative therapy.
    Ozcan Kara P; Sari O; Gedik GK; Kocak I; Kaya B
    Rev Esp Med Nucl; 2011; 30(1):36-7. PubMed ID: 21211869
    [No Abstract]   [Full Text] [Related]  

  • 17. Lung metastases in patients with differentiated thyroid carcinoma and evaluation of response to radioiodine therapy.
    Kalender E; Zeki Celen Y; Elboga U; Deniz Demir H; Yilmaz M
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):328-31. PubMed ID: 23084016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False-Positive Uptake of 131I Due to Tubal Ligation in a Patient With Papillary Thyroid Cancer.
    Tong J; Jin Y; Liu M; Lv Z; Chen L
    Clin Nucl Med; 2018 May; 43(5):375-376. PubMed ID: 29517545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal Metastasis From Primary Thyroid Cancer on 131I and MRI Imaging.
    Patel DR; Kamat BH; Farwell MD
    Clin Nucl Med; 2017 Jan; 42(1):70-72. PubMed ID: 27846002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroelastic pseudotumor elastofibroma dorsi detected by
    Oporto M; Cepa F; Orta N; Rubí S; Navalón H; Peña C
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(1):46-49. PubMed ID: 28522155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.